We are business model innovators and have successfully created new financial models before; team has done $10B+ in transactions in last two decades.
We are applying those same tehniques in the US pharma space and are in the midst of a multi-billion dollar generic pharma transaction. We are reverse engineering the 1) procurement / purchasing / supply chain model and 2) the financial economics behind it as it applies to generic drugs.
Current deal strucuture will be disclosed to selected indivuduals.
We are specifically looking for individuals with far reach in the MENA region who:
- Have been involved in large deals in the US (each deal no less than $500mm)
- Have intimate relationships with high-net worth MENA individuals/families or Mena-based Funds looking for secure, high-yield opportunities.
You will be part of the deal team and will be paid on the execution of the current transaction (your payout will vary depending on multiple factors but can expect $15mm-$50mm).
OUR MODEL BRINGS THE FOLLOWING BENEFITS TO THE FUNDERS:
Private Equity Funds: Rapidly accelerate revenue and EBITDA growth for select portfolio companies. Find new acquisitions without any additional capital outlay.
Hedge Funds: Fund deals that accelerate long or short market positions.
Large Limited Partnerships: Pension funds, soverign wealth funds, insurance companies and others can tap into yield opportunities that are low-risk and provide steady fixed returns.
- Consumer Electronics
- Business Development